{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:26:30Z","timestamp":1793499990677,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.cyto.2024.156726","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:43:30Z","timestamp":1722991410000},"page":"156726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Natural killer cell-associated prognosis model characterizes immune landscape and treatment efficacy of diffuse large B cell lymphoma"],"prefix":"10.1016","volume":"182","author":[{"given":"Wei","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8506-7359","authenticated-orcid":false,"given":"Yunxin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cyto.2024.156726_b0005","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse Large B-Cell Lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6769","key":"10.1016\/j.cyto.2024.156726_b0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.cyto.2024.156726_b0015","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","article-title":"Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte","volume":"23","author":"Feugier","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156726_b0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cyto.2024.156726_b0025","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/leu.2017.251","article-title":"Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets","volume":"32","author":"Karube","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.cyto.2024.156726_b0030","doi-asserted-by":"crossref","unstructured":"G. Lenz, G. Wright, S.S. Dave, W. Xiao, J. Powell, H. Zhao, W. Xu, B. Tan, N. Goldschmidt, J. Iqbal, J. Vose, M. Bast, K. Fu, D.D. Weisenburger, T.C. Greiner, J.O. Armitage, A. Kyle, L. May, R.D. Gascoyne, J.M. Connors, G. Troen, H. Holte, S. Kvaloy, D. Dierickx, G. Verhoef, J. Delabie, E.B. Smeland, P. Jares, A. Martinez, A. Lopez-Guillermo, E. Montserrat, E. Campo, R.M. Braziel, T.P. Miller, L.M. Rimsza, J.R. Cook, B. Pohlman, J. Sweetenham, R.R. Tubbs, R.I. Fisher, E. Hartmann, A. Rosenwald, G. Ott, H.K. Muller-Hermelink, D. Wrench, T.A. Lister, E.S. Jaffe, W.H. Wilson, W.C. Chan, L.M. Staudt, P. Lymphoma\/Leukemia Molecular Profiling, Stromal gene signatures in large-B-cell lymphomas, N Engl J Med 359(22) (2008) 2313-23.","DOI":"10.1056\/NEJMoa0802885"},{"issue":"3","key":"10.1016\/j.cyto.2024.156726_b0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cyto.2024.156726_b0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2024.156726_b0045","doi-asserted-by":"crossref","first-page":"1018685","DOI":"10.3389\/fimmu.2022.1018685","article-title":"Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC","volume":"13","author":"Chi","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156726_b0050","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156726_b0055","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cell.2020.01.022","article-title":"Tissue Determinants of Human NK Cell Development, Function, and Residence","volume":"180","author":"Dogra","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cyto.2024.156726_b0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","article-title":"Control of Metastasis by NK Cells","volume":"32","author":"Lopez-Soto","year":"2017","journal-title":"Cancer Cell"},{"issue":"22","key":"10.1016\/j.cyto.2024.156726_b0065","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1158\/1078-0432.CCR-21-0971","article-title":"FLT3L release by natural killer cells enhances response to radioimmunotherapy in preclinical models of HNSCC","volume":"27","author":"Bickett","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"9244","key":"10.1016\/j.cyto.2024.156726_b0070","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","article-title":"Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population","volume":"356","author":"Imai","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2024.156726_b0075","article-title":"Identification and validation of a novel signature based on NK cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma by integrated analysis of single-cell and Bulk RNA-sequencing","volume":"13","author":"Song","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156726_b0080","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P","article-title":"The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma","volume":"79","author":"Coca","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.cyto.2024.156726_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.724107","article-title":"A transcriptional signature of PDGF-DD activated natural killer cells predicts more favorable prognosis in low-grade glioma","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156726_b0090","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41467-018-03618-w","article-title":"Transcriptomic signatures of NK cells suggest impaired responsiveness in HIV-1 infection and increased activity post-vaccination","volume":"9","author":"Costanzo","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cyto.2024.156726_b0095","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1080\/07853890.2021.1914343","article-title":"Bioinformatics reveal macrophages marker genes signature in breast cancer to predict prognosis","volume":"53","author":"Li","year":"2021","journal-title":"Ann. Med."},{"key":"10.1016\/j.cyto.2024.156726_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.711020","article-title":"Integration of scRNA-Seq and Bulk RNA-Seq to analyse the heterogeneity of ovarian cancer immune cells and establish a molecular risk model","volume":"11","author":"Liang","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156726_b0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41423-019-0214-4","article-title":"Revolutionizing immunology with single-cell RNA sequencing","volume":"16","author":"Chen","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156726_b0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.cyto.2024.156726_b0115","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"10","key":"10.1016\/j.cyto.2024.156726_b0120","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.cyto.2024.156726_b0125","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/gb-2014-15-3-r47","article-title":"Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines","volume":"15","author":"Geeleher","year":"2014","journal-title":"Genome Biol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156726_b0130","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1182\/bloodadvances.2021004618","article-title":"A germinal center-associated microenvironmental signature reflects malignant phenotype and outcome of DLBCL","volume":"6","author":"Miyawaki","year":"2022","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.cyto.2024.156726_b0135","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"23","key":"10.1016\/j.cyto.2024.156726_b0140","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.2019002729","article-title":"International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI","volume":"135","author":"Ruppert","year":"2020","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cyto.2024.156726_b0145","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/annonc\/mdp531","article-title":"Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story","volume":"21","author":"Bari","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cyto.2024.156726_b0150","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9972927","article-title":"Natural killer cell dysfunction in obese patients with breast cancer: a review of a triad and its implications","volume":"2021","author":"Elaraby","year":"2021","journal-title":"J. Immunol. Res."},{"issue":"8","key":"10.1016\/j.cyto.2024.156726_b0155","doi-asserted-by":"crossref","first-page":"e952197","DOI":"10.4161\/21624011.2014.952197","article-title":"NK cells and T cells cooperate during the clinical course of colorectal cancer","volume":"3","author":"Sconocchia","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cyto.2024.156726_b0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.smim.2017.08.002","article-title":"Natural killer cell-mediated immunosurveillance of human cancer","volume":"31","author":"Malmberg","year":"2017","journal-title":"Semin. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156726_b0165","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jaci.2013.07.020","article-title":"Natural killer cell deficiency","volume":"132","author":"Orange","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2024.156726_b0170","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jtho.2020.05.008","article-title":"Harnessing natural killer immunity in metastatic SCLC","volume":"15","author":"Best","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156726_b0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0304-3835(00)00542-5","article-title":"Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer","volume":"159","author":"Ishigami","year":"2000","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.cyto.2024.156726_b0180","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/2326-6066.CIR-18-0500","article-title":"A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients","volume":"7","author":"Cursons","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.cyto.2024.156726_b0185","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143762","article-title":"The changing role of natural killer cells in cancer metastasis","volume":"132","author":"Chan","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.cyto.2024.156726_b0190","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202001134","article-title":"Cancer cells educate natural killer cells to a metastasis-promoting cell state","volume":"219","author":"Chan","year":"2020","journal-title":"J. Cell Biol."},{"issue":"26","key":"10.1016\/j.cyto.2024.156726_b0195","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2015.65.6520","article-title":"CNS international prognostic index: a risk model for CNS relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"34","author":"Schmitz","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156726_b0200","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-9440(10)63150-1","article-title":"Building an outcome predictor model for diffuse large B-cell lymphoma","volume":"164","author":"Saez","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156726_b0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1148\/radiol.2019190872","article-title":"Comparison of a deep learning risk score and standard mammographic density score for breast cancer risk prediction","volume":"294","author":"Dembrower","year":"2020","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.cyto.2024.156726_b0210","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1182\/blood-2007-09-111658","article-title":"Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era","volume":"112","author":"Habermann","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156726_b0215","first-page":"609","article-title":"Ferroptosis-Related gene signature: a new method for personalized risk assessment in patients with diffuse large B-Cell lymphoma","volume":"14","author":"Chen","year":"2021","journal-title":"Pharmgenomics Pers. Med."},{"issue":"6","key":"10.1016\/j.cyto.2024.156726_b0220","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00401-016-1536-2","article-title":"Genomic characterization of primary central nervous system lymphoma","volume":"131","author":"Fukumura","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"52","key":"10.1016\/j.cyto.2024.156726_b0225","doi-asserted-by":"crossref","first-page":"86433","DOI":"10.18632\/oncotarget.13239","article-title":"Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cyto.2024.156726_b0230","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pathol.2019.09.014","article-title":"The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma","volume":"52","author":"Xu","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.cyto.2024.156726_b0235","article-title":"Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma","author":"Forberg","year":"2023","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cyto.2024.156726_b0240","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.canlet.2020.10.024","article-title":"NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma","volume":"497","author":"Lu","year":"2021","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.cyto.2024.156726_b0245","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.clml.2018.07.288","article-title":"LAMP1 Overexpression Predicts for Poor Prognosis in Diffuse Large B-cell Lymphoma","volume":"18","author":"Dang","year":"2018","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"7","key":"10.1016\/j.cyto.2024.156726_b0250","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.pathol.2016.08.001","article-title":"LAMP1 expression is associated with malignant behaviours and predicts unfavourable prognosis in laryngeal squamous cell carcinoma","volume":"48","author":"Lu","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.cyto.2024.156726_b0255","doi-asserted-by":"crossref","unstructured":"C.B. Steen, B.A. Luca, M.S. Esfahani, A. Azizi, B.J. Sworder, B.Y. Nabet, D.M. Kurtz, C.L. Liu, F. Khameneh, R.H. Advani, Y. Natkunam, J.H. Myklebust, M. Diehn, A.J. Gentles, A.M. Newman, A.A. Alizadeh, The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma, Cancer Cell 39(10) (2021) 1422-1437 e10.","DOI":"10.1016\/j.ccell.2021.08.011"},{"issue":"12","key":"10.1016\/j.cyto.2024.156726_b0260","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1093\/annonc\/mdy450","article-title":"Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue","volume":"29","author":"Ciavarella","year":"2018","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156726_b0265","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.leukres.2014.09.007","article-title":"Microvascular density, CD68 and tryptase expression in human diffuse large B-cell lymphoma","volume":"38","author":"Marinaccio","year":"2014","journal-title":"Leuk. Res."},{"issue":"3","key":"10.1016\/j.cyto.2024.156726_b0270","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1015587423262","article-title":"Tumors and inflammatory infiltrates: friends or foes?","volume":"19","author":"Brigati","year":"2002","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.cyto.2024.156726_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102443","article-title":"Treatment strategies for patients with diffuse large B-cell lymphoma","volume":"110","author":"Poletto","year":"2022","journal-title":"Cancer Treat. Rev."},{"issue":"10216","key":"10.1016\/j.cyto.2024.156726_b0280","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/S0140-6736(19)33008-9","article-title":"Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial","volume":"394","author":"Poeschel","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cyto.2024.156726_b0285","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.critrevonc.2012.12.009","article-title":"Diffuse large B-cell lymphoma","volume":"87","author":"Martelli","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cyto.2024.156726_b0290","doi-asserted-by":"crossref","unstructured":"R. Schmitz, G.W. Wright, D.W. Huang, C.A. Johnson, J.D. Phelan, J.Q. Wang, S. Roulland, M. Kasbekar, R.M. Young, A.L. Shaffer, D.J. Hodson, W. Xiao, X. Yu, Y. Yang, H. Zhao, W. Xu, X. Liu, B. Zhou, W. Du, W.C. Chan, E.S. Jaffe, R.D. Gascoyne, J.M. Connors, E. Campo, A. Lopez-Guillermo, A. Rosenwald, G. Ott, J. Delabie, L.M. Rimsza, K. Tay Kuang Wei, A.D. Zelenetz, J.P. Leonard, N.L. Bartlett, B. Tran, J. Shetty, Y. Zhao, D.R. Soppet, S. Pittaluga, W.H. Wilson, L.M. Staudt, Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma, N Engl J Med 378(15) (2018) 1396-1407.","DOI":"10.1056\/NEJMoa1801445"},{"issue":"16","key":"10.1016\/j.cyto.2024.156726_b0295","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2017-07-796342","article-title":"Immune evasion via PD-1\/PD-L1 on NK cells and monocyte\/macrophages is more prominent in Hodgkin lymphoma than DLBCL","volume":"131","author":"Vari","year":"2018","journal-title":"Blood"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T21:00:40Z","timestamp":1725051640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624002291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":59,"alternative-id":["S1043466624002291"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156726","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cell-associated prognosis model characterizes immune landscape and treatment efficacy of diffuse large B cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156726"}}